These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 12837117)

  • 21. The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone.
    Mizuno T; Katsumata N; Mukai H; Shimizu C; Ando M; Watanabe T
    Support Care Cancer; 2007 Mar; 15(3):287-91. PubMed ID: 16941132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies.
    Cherif H; Johansson E; Björkholm M; Kalin M
    Haematologica; 2006 Feb; 91(2):215-22. PubMed ID: 16461306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The outpatient management of febrile neutropenia in cancer patients.
    Freifeld AG; Pizzo PA
    Oncology (Williston Park); 1996 Apr; 10(4):599-606, 611-2; discussion 615-6. PubMed ID: 8723296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia.
    Karaman S; Vural S; Yildirmak Y; Emecen M; Erdem E; Kebudi R
    Pediatr Blood Cancer; 2012 Apr; 58(4):579-83. PubMed ID: 21674768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer.
    Rubenstein EB; Rolston K; Benjamin RS; Loewy J; Escalante C; Manzullo E; Hughes P; Moreland B; Fender A; Kennedy K
    Cancer; 1993 Jun; 71(11):3640-6. PubMed ID: 8490912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in management of low-risk febrile neutropenia.
    Teuffel O; Sung L
    Curr Opin Pediatr; 2012 Feb; 24(1):40-5. PubMed ID: 22037219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer.
    Aquino VM; Herrera L; Sandler ES; Buchanan GR
    Cancer; 2000 Apr; 88(7):1710-4. PubMed ID: 10738231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
    Ahmed N; El-Mahallawy HA; Ahmed IA; Nassif S; El-Beshlawy A; El-Haddad A
    Pediatr Blood Cancer; 2007 Nov; 49(6):786-92. PubMed ID: 17366527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefepime monotherapy for treatment of febrile neutropenia in children.
    Ariffin H; Ai CL; Lee CL; Abdullah WA
    J Paediatr Child Health; 2006 Dec; 42(12):781-4. PubMed ID: 17096713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
    Klastersky J; Paesmans M; Georgala A; Muanza F; Plehiers B; Dubreucq L; Lalami Y; Aoun M; Barette M
    J Clin Oncol; 2006 Sep; 24(25):4129-34. PubMed ID: 16943529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outpatient antibiotic treatment in low-risk febrile neutropenic cancer patients.
    Escalante CP; Rubenstein EB; Rolston KV
    Support Care Cancer; 1996 Sep; 4(5):358-63. PubMed ID: 8883229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Paganini H; Gómez S; Ruvinsky S; Zubizarreta P; Latella A; Fraquelli L; Iturres AS; Casimir L; Debbag R
    Cancer; 2003 Apr; 97(7):1775-80. PubMed ID: 12655535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
    Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
    N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients.
    Mullen CA
    Pediatr Infect Dis J; 2003 Dec; 22(12):1138-42. PubMed ID: 14688588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of febrile neutropenia in pediatric oncology patients: a Canadian survey.
    Boragina M; Patel H; Reiter S; Dougherty G
    Pediatr Blood Cancer; 2007 May; 48(5):521-6. PubMed ID: 16724314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methodology for clinical trials involving patients with cancer who have febrile neutropenia: updated guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studies.
    Feld R; Paesmans M; Freifeld AG; Klastersky J; Pizzo PA; Rolston KV; Rubenstein E; Talcott JA; Walsh TJ; ;
    Clin Infect Dis; 2002 Dec; 35(12):1463-8. PubMed ID: 12471564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer.
    Alexander SW; Wade KC; Hibberd PL; Parsons SK
    J Pediatr Hematol Oncol; 2002 Jan; 24(1):38-42. PubMed ID: 11902738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Outpatient antibiotherapy in children with neutropenia and fever. A review of the literature].
    Leverger G
    Presse Med; 2004 Mar; 33(5):330-7. PubMed ID: 15041885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early Discontinuation versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients with Febrile Neutropenia, Before Recovery of Counts: A Randomized Controlled Trial (DALFEN Study).
    Kumar A; Biswas B; Chopra A; Kapil A; Vishnubhatla S; Bakhshi S
    Indian J Pediatr; 2021 Mar; 88(3):240-245. PubMed ID: 32537711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of the febrile neutropenic patient.
    Picazo JJ;
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.